Lexeo Therapeutics
LXEO
Insidertransaktionen und Aktienkurs 2024-2026
Alle Insidertrades bei Lexeo Therapeutics
| Datum |
Typ |
Insider |
Position |
Ø-Preis |
Volumen |
|
1.7.2026
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
4,5 $ |
116.243 $ |
|
1.7.2026
|
Verkauf |
Otero, Jose Manuel |
Chief Operating Officer |
4,5 $ |
20.904 $ |
|
1.7.2026
|
Verkauf |
Tamayo, Louis Edward |
Chief Financial Officer |
4,5 $ |
20.838 $ |
|
1.7.2026
|
Verkauf |
Bhalla, Narinder Pal |
Chief Medical Officer |
4,4 $ |
98.593 $ |
|
18.5.2026
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
5,1 $ |
16.927 $ |
|
18.5.2026
|
Verkauf |
Otero, Jose Manuel |
Chief Operating Officer |
5,1 $ |
6.606 $ |
|
6.4.2026
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
5,7 $ |
313.137 $ |
|
18.2.2026
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
6,4 $ |
64.924 $ |
|
18.2.2026
|
Verkauf |
Otero, Jose Manuel |
Chief Operating Officer |
6,4 $ |
19.294 $ |
|
18.11.2025
|
Verkauf |
Otero, Jose Manuel |
Chief Operating Officer |
9,3 $ |
6.684 $ |
|
18.11.2025
|
Verkauf |
Adler, Eric |
Chief Medical Officer |
9,3 $ |
5.701 $ |
|
18.11.2025
|
Verkauf |
Robertson, Jenny |
Chief Legal Officer |
9,3 $ |
5.089 $ |
|
18.11.2025
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
9,3 $ |
10.447 $ |
|
18.11.2025
|
Verkauf |
See, Tai Sandi |
Chief Development Officer |
9,3 $ |
3.578 $ |
|
17.10.2025
|
Verkauf |
Adler, Eric |
Chief Medical Officer |
9,2 $ |
30.242 $ |
|
17.10.2025
|
Verkauf |
Robertson, Jenny |
Chief Legal Officer |
9,2 $ |
31.529 $ |
|
17.10.2025
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
9,2 $ |
117.436 $ |
|
17.10.2025
|
Verkauf |
See, Tai Sandi |
Chief Development Officer |
9,2 $ |
34.767 $ |
|
17.10.2025
|
Verkauf |
Otero, Jose Manuel |
Chief Technical Officer |
9,2 $ |
18.912 $ |
|
18.8.2025
|
Verkauf |
Otero, Jose Manuel |
Chief Technical Officer |
7,0 $ |
19.978 $ |
|
18.8.2025
|
Verkauf |
See, Tai Sandi |
Chief Development Officer |
4,7 $ |
1.783 $ |
|
18.8.2025
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
4,7 $ |
17.972 $ |
|
18.8.2025
|
Verkauf |
Adler, Eric |
Chief Medical Officer |
4,7 $ |
2.838 $ |
|
18.8.2025
|
Verkauf |
Robertson, Jenny |
Chief Legal Officer |
4,7 $ |
2.530 $ |
|
16.5.2025
|
Verkauf |
See, Tai Sandi |
Chief Development Officer |
2,8 $ |
1.018 $ |
|
16.5.2025
|
Verkauf |
Robertson, Jenny |
Chief Legal Officer |
2,8 $ |
1.445 $ |
|
16.5.2025
|
Verkauf |
Adler, Eric |
Chief Medical Officer |
2,8 $ |
1.623 $ |
|
16.5.2025
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
2,8 $ |
2.979 $ |
|
19.2.2025
|
Verkauf |
Robertson, Jenny |
Chief Legal Officer |
4,4 $ |
9.272 $ |
|
19.2.2025
|
Verkauf |
Adler, Eric |
Chief Medical Officer |
4,4 $ |
10.410 $ |
|
19.2.2025
|
Verkauf |
See, Tai Sandi |
Chief Development Officer |
4,4 $ |
6.558 $ |
|
19.2.2025
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
4,4 $ |
19.091 $ |
|
10.12.2024
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
8,2 $ |
20.491 $ |
|
25.11.2024
|
Kauf |
Cholmondeley, Paula H. |
Aufsichtsrat |
7,0 $ |
104.852 $ |
|
11.11.2024
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
7,8 $ |
19.557 $ |
|
10.10.2024
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
8,1 $ |
40.496 $ |
|
10.9.2024
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
10,7 $ |
53.274 $ |
|
12.8.2024
|
Verkauf |
Townsend, Richard Nolan |
Chief Executive Officer |
11,5 $ |
57.635 $ |
Alle Angaben ohne Gewähr! Keine Empfehlung/Beratung! © U.S. Securities and Exchange Commission (SEC)
Kostenlose Updates per Mail
Bestätige noch deine Email-Adresse